[
    [
        {
            "time": "2020-04-15",
            "original_text": "Novartis to Manufacture Mass General's Coronavirus Vaccine Candidate",
            "features": {
                "keywords": [
                    "Novartis",
                    "Manufacture",
                    "Mass General",
                    "Coronavirus",
                    "Vaccine",
                    "Candidate"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2020-05-10",
            "original_text": "Coronavirus update: Novartis enters vaccine race as reopenings, testing efforts ramp up",
            "features": {
                "keywords": [
                    "Coronavirus",
                    "update",
                    "Novartis",
                    "vaccine",
                    "race",
                    "reopenings",
                    "testing",
                    "efforts",
                    "ramp",
                    "up"
                ],
                "sentiment_score": 0.65,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "biotech"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 6,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "2020-06-25",
            "original_text": "Big Day for Data: GDP, Jobless Claims, Novartis, Durable Goods & More",
            "features": {
                "keywords": [
                    "Big Day",
                    "Data",
                    "GDP",
                    "Jobless Claims",
                    "Novartis",
                    "Durable Goods"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "economy",
                    "healthcare",
                    "manufacturing"
                ],
                "causal_factor": "false",
                "causal_impact": "none",
                "affected_by_time_series": "true",
                "ts_effect_direction": "mixed"
            },
            "scores": {
                "Correlation": 7,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 5
            }
        },
        {
            "time": "2020-07-18",
            "original_text": "Novartis to make U.S. researchers' COVID-19 gene therapy vaccine hopeful",
            "features": {
                "keywords": [
                    "Novartis",
                    "make",
                    "U.S.",
                    "researchers",
                    "COVID-19",
                    "gene",
                    "therapy",
                    "vaccine",
                    "hopeful"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "biotech"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 7,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        }
    ]
]